Wang Chan – Trademark Portfolio

Entity Type: 01

Wang Chan holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AMONOY and MEDKUL. The owner is based in Anqing City, Anhui.

No. 19, Wangwu Group, Nandou Village

Baili Town, Taihu County

Anqing City, Anhui 246000 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEDKUL
MEDKUL
Registered 2023
AMONOY
AMONOY
Registered 2020
AMONOY
AMONOY
Cancelled 2019

Trademark Classifications

Wang Chan's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

25
Clothing (1 filing)

Clothing, footwear, headgear

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Wang Chan have?

Wang Chan has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does Wang Chan file in?

Wang Chan files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 25 (Clothing), Class 12 (Vehicles). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Wang Chan's most well-known trademarks?

Wang Chan's registered trademark portfolio includes well-known marks such as AMONOY and MEDKUL. These are among 2 currently registered trademarks in the portfolio.

What is Wang Chan's trademark registration success rate?

Wang Chan has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.